Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients  Finnian R. Mc Causland, Sushrut S.

Slides:



Advertisements
Similar presentations
Vitamin D levels and patient outcome in chronic kidney disease
Advertisements

Volume 77, Issue 12, Pages (June 2010)
Volume 69, Issue 11, Pages (June 2006)
Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease  Connie M. Rhee, MD, MSc, Kamyar Kalantar-Zadeh, MD, MPH, PhD, Vanessa Ravel,
Anemia management in chronic kidney disease
Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients  Jiacong Luo, MD, MS, MPH, Donna E.
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
C-reactive protein and dialysis access
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients  G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
The risk of hospitalization and modality failure with home dialysis
C-reactive protein and dialysis access
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Volume 83, Issue 6, Pages (June 2013)
Type of vascular access and mortality in U.S. hemodialysis patients
Volume 80, Issue 2, Pages (July 2011)
Volume 86, Issue 4, Pages (October 2014)
Volume 85, Issue 1, Pages (January 2014)
Volume 88, Issue 2, Pages (August 2015)
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Volume 82, Issue 1, Pages (July 2012)
Volume 81, Issue 3, Pages (February 2012)
Volume 79, Issue 12, Pages (June 2011)
Volume 63, Issue 4, Pages (April 2003)
Volume 93, Issue 1, Pages (January 2018)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Volume 68, Issue 6, Pages (December 2005)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 68, Issue 4, Pages (October 2005)
Volume 76, Issue 10, Pages (November 2009)
Volume 80, Issue 9, Pages (November 2011)
Dietary phosphorus is associated with greater left ventricular mass
Volume 86, Issue 4, Pages (October 2014)
Volume 68, Issue 5, Pages (November 2005)
Volume 77, Issue 7, Pages (April 2010)
Renal risk scores: Progress and prospects
Volume 92, Issue 2, Pages (August 2017)
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
U-shaped effect of eGFR and mortality
Volume 83, Issue 4, Pages (April 2013)
Volume 75, Issue 1, Pages (January 2009)
Volume 86, Issue 3, Pages (September 2014)
Volume 65, Issue 3, Pages (March 2004)
Vitamin D levels and patient outcome in chronic kidney disease
Volume 76, Issue 3, Pages (August 2009)
Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States  George A. Kaysen, MD, PhD, Kirsten.
Volume 76, Issue 1, Pages (July 2009)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 73, Issue 8, Pages (April 2008)
Volume 84, Issue 4, Pages (October 2013)
Volume 82, Issue 3, Pages (August 2012)
Volume 74, Issue 8, Pages (October 2008)
Volume 74, Issue 9, Pages (November 2008)
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
Volume 61, Issue 1, Pages (January 2002)
Volume 75, Issue 1, Pages (January 2009)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Volume 63, Pages S13-S16 (February 2003)
Volume 87, Issue 3, Pages (March 2015)
Sushrut S. Waikar, MD, MPH, Gary C. Curhan, MD, ScD, Steven M
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Changes to the End-Stage Renal Disease Quality Incentive Program
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 61, Issue 2, Pages (February 2002)
Volume 77, Issue 12, Pages (June 2010)
Volume 58, Issue 5, Pages (November 2000)
Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.
Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation  Theodore.
Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients  Finnian R. Mc Causland, Sushrut S. Waikar, Steven M. Brunelli  Kidney International  Volume 82, Issue 2, Pages 204-211 (July 2012) DOI: 10.1038/ki.2012.42 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Daily dietary sodium intake. Distribution of daily dietary sodium intake (mg/day; a), sodium:calorie intake ratio (mg/kcal; b), sodium:potassium intake ratio (mg/mg; c), and prescribed dietary sodium intake (mg/day; d) at baseline. Kidney International 2012 82, 204-211DOI: (10.1038/ki.2012.42) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Hazard ratios (HRs) (95% confidence intervals (CIs)) between measures of daily sodium intake and all-cause mortality. Sodium was considered as total intake (mg/day), sodium:calorie intake ratio (Na:Cal; mg/kcal), and sodium:potassium intake ratio (Na:K; mg/mg). Unadjusted estimates are indicated by circles. Estimates from Model 1 (squares) were adjusted for age, sex, race (black vs. non-black), HEMO Study Kt/V and flux group assignments, post-dialysis weight, sex-by-post-weight cross-product terms, access (fistula, graft, and catheter), congestive heart failure status (none, mild, and moderate/severe), the presence/absence of diabetes and ischemic heart disease, urine volume (≤200 and >200ml/day), and dialysis session length (≤180, 181–209, 210–239, and ≥240min). Estimates from Model 2 (triangles) were additionally adjusted for serum sodium, albumin (≤3.5, 3.5–4.0, and >4.0g/dl), phosphorus, creatinine, and ultrafiltration requirement. All models were stratified on clinical center. Kidney International 2012 82, 204-211DOI: (10.1038/ki.2012.42) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 Association between quartiles of dietary sodium intake and mortality. Hazard ratios (95% confidence intervals (CIs)) for all-cause mortality according to quartiles (Q; referent Q1) of reported daily dietary sodium intake (mg/day; a), daily sodium:calorie intake ratio (mg/kcal; b), and sodium:potassium intake ratio (mg/mg; c). Estimates from Model 1 were adjusted for age, sex, race (black vs. non-black), HEMO Study Kt/V and flux group assignments, post-dialysis weight, sex-by-post-weight cross-product terms, access (fistula, graft, and catheter), congestive heart failure status (none, mild, and moderate/severe), the presence/absence of diabetes and ischemic heart disease, urine volume (≤200 and >200ml/day), and dialysis session length (≤180, 181–209, 210–239, and ≥240min). Estimates from Model 2 were additionally adjusted for serum sodium, albumin (≤3.5, 3.5–4.0, and >4.0g/dl), phosphorus, creatinine, and ultrafiltration requirement. All models were stratified on clinical center. Kidney International 2012 82, 204-211DOI: (10.1038/ki.2012.42) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 4 Association between prescribed sodium restriction and mortality. Associations between liberal (>2g/day) and restrictive (≤2g/day; referent group; hazard ratio (HR)=1, not shown) prescribed sodium restriction and all-cause mortality. Estimates from Model 1 were adjusted for age, sex, race (black vs. non-black), HEMO Study Kt/V and flux group assignments, post-dialysis weight, sex-by-post-weight cross-product terms, access (fistula, graft, and catheter), congestive heart failure status (none, mild, and moderate/severe), the presence/absence of diabetes and ischemic heart disease, urine volume (≤200 and >200ml/day), and dialysis session length (≤180, 181–209, 210–239, and ≥240min). Estimates from Model 2 were additionally adjusted for serum sodium, albumin (≤3.5, 3.5–4.0, and >4.0g/dl), phosphorus, creatinine, and ultrafiltration requirement. All models were stratified on clinical center. CI, confidence interval. Kidney International 2012 82, 204-211DOI: (10.1038/ki.2012.42) Copyright © 2012 International Society of Nephrology Terms and Conditions